3 completed, 1 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Unknown 1 |
Follow Bone Density: new trials by email Literature Review of Bone Density trials Research Report on Bone Density
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Baricitinib Treatment on Peripheral Bone in RA Baricitinib - Rheumatoid Arthritis, Bone Density | Phase 3 | Unknown | University of Erlangen-Nürnberg Medical School | 15 | 2018-09-11 | 2021-01-15 |
| Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study Denosumab 60 MG [Prolia], Placebo Injection, Alendronate 70Mg Tab - Bone Density, Bone Loss | Phase 3 | Completed | Massachusetts General Hospital | 30 | 2017-10-25 | 2025-11-04 |
| The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause Juvent 1000 Dynamic Motion Therapy (DMT) Platform - Bone Density, Osteopenia | Phase 3 | Completed | University Health Network, Toronto | 202 | 2006-11-01 | 2010-04-08 |
| ATAC - Bone Density Sub-Protocol Anastrozole, Tamoxifen - Bone Density | Phase 3 | Completed | AstraZeneca | 308 | 1998-06-01 | 2009-04-27 |
Bone Diseases, Metabolic (2) · Anorexia Nervosa (1) · Arthritis, Rheumatoid (1) · Feeding and Eating Disorders (1) · Osteoporosis (1)
Musculoskeletal Diseases (3) · Bone Diseases (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Mental Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Rheumatic Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1) · Skin and Connective Tissue Diseases (1)
Alendronate (1) · Anastrozole (1) · Denosumab (1) · Tamoxifen (1) · baricitinib (1)
AstraZeneca (1) · Massachusetts General Hospital (1) · University Health Network, Toronto (1) · University of Erlangen-Nürnberg Medical School (1)
Canada (1) · Germany (1) · United States (1)
Angela M Cheung, M.D., Ph.D. (1) · Arnd Kleyer, MD (1) · Karen K Miller, MD (1)